FDA Inspection 1314440 — Baylor University Medical Center Transfusion Services
The FDA completed an inspection of Baylor University Medical Center Transfusion Services on April 22, 2026 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)